Comparison of risedronate, alendronate, zoledronate, and ibandronate in those with low BMD
Clinical effectiveness of bisphosphonates for the prevention of fragility fractures: A systematic review and network meta-analysisBone. 2016 Aug;89:52-8
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
A total of 27 randomized controlled trials were included in this network meta-analysis investigating the comparative efficacies of bisphosphonates - including alendronate, ibandronate, risedronate, and zoledronic acid - versus placebo or control in patients with low bone mineral density. All studied drugs demonstrated significant effects on vertebral fracture incidence and bone mineral density of ...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE